PE regimen: Clinical Trials

2 trials of PE regimen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Unknown 1
Phase 21Unknown 1

Follow PE regimen: new trials by email Literature Review of PE regimen trials Research Report on PE regimen

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer
Surufatinib,Etoposide,Cisplatin,Toripalimab, Surufatinib,Etoposide,Cisplatin - Small Cell Lung Carcinoma
Phase 1 / Phase 2UnknownSun Yat-sen University882021-11-092022-11-14
A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer
ABT-263, etoposide/cisplatin - Solid Tumors
Phase 1CompletedAbbVie (prior sponsor, Abbott)122009-10-012018-06-06

Conditions studied

Small Cell Lung Carcinoma (1)

Sponsors

AbbVie (prior sponsor, Abbott) (1)  ·  Sun Yat-sen University (1)

Countries

China (1)  ·  United States (1)

Top investigators

Mack Mabry, MD (1)

Results publications

PMID 39327433